Dupixent can be used for several conditions, once of which is treating ongoing nasal and sinus inflammation due to nasal polyps. It can be used for both adults and certain children. Dupixent is an ...
Approval in adults and children aged 6 years and older supported by phase 3 study demonstrating Dupixent significantly reduced nasal signs and symptoms and systemic corticosteroid use or surgery ...
Patients receiving dupilumab showed clinical improvement in nasal congestion and smell, and were less likely to require systemic corticosteroids or additional sino-nasal surgery. The Food and Drug ...
TARRYTOWN, N.Y. and PARIS, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Please provide your email address to receive an email when new articles are posted on . EVEREST represents the first head-to-head study of these biologics for CRSwNP. Differences between the biologics ...
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) and a ...
Dupixent (dupilumab) is a prescription drug that works to treat certain inflammatory conditions. It does so by reducing inflammation signals in your immune system. Your response to this drug may vary ...
One of the most bothersome things about being sick or having seasonal allergies is that it makes your nose stuffy and blocked. This makes breathing in through your nostrils frustrating—if not ...
Dupixent works by blocking two proteins in your body called IL-4 and IL-13 (interleukins). These are a specific type of protein that can trigger the immune system to respond as if there’s danger when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results